Sensitivity of <i>Streptococcus</i> <i>viridans</i> to antibacterial agents in HIV-positive patients coupled to respiratory diseases

The streptococcus group consists of multiple species of globular Gram-positive facultative anaerobic bacteria, the classification of which is based on assessing their capacity to erythrocyte hemolysis. The viridans group streptococci produce a green coloration being a part of normal microflora in th...

Full description

Bibliographic Details
Main Authors: L. V. Puzyreva, A. V. Mordyk, L. A. Rodkina, I. V. Zhitina, A. V. Timofeeva
Format: Article
Language:Russian
Published: Sankt-Peterburg : NIIÈM imeni Pastera 2021-03-01
Series:Инфекция и иммунитет
Subjects:
Online Access:https://www.iimmun.ru/iimm/article/view/1241
_version_ 1797973086258069504
author L. V. Puzyreva
A. V. Mordyk
L. A. Rodkina
I. V. Zhitina
A. V. Timofeeva
author_facet L. V. Puzyreva
A. V. Mordyk
L. A. Rodkina
I. V. Zhitina
A. V. Timofeeva
author_sort L. V. Puzyreva
collection DOAJ
description The streptococcus group consists of multiple species of globular Gram-positive facultative anaerobic bacteria, the classification of which is based on assessing their capacity to erythrocyte hemolysis. The viridans group streptococci produce a green coloration being a part of normal microflora in the oral cavity. However, in case of developing immunodeficiency states, oncology, and neutropenia, this pathogen can cause diseases such as bacteremia, sepsis, endocarditis, as well as pneumonia in some cases. Respiratory diseases commonly require medical assistance in HIV-infected patient cohort. The role of commensal S. viridans in development of bacterial diseases in HIV-infected patients remains poorly examined. A potential association between S. viridans and other bacterial communities, including pathogenic microorganisms is obscure. In addition, it might be worth evaluating sensitivity of S. viridans to antibacterial agents in regions with high HIV infection incidence. The aim of the study was to evaluate sensitivity to antibiotics in sputum viridans group streptococci collected from HIV-infected patients with symptomatic pneumonia. Materials and methods. The data on sputum microbiological study conducted within the 01.01.2012—01.01.2019 interval were collected from all HIV-infected patients with suspected pneumonia (n = 684) and analyzed at the Infectious Clinical Hospital No. 1 named after D.M. Dalmatov, among which S. viridans was detected in 193 patients (28.2%). Bacteriological examination of patient samples was conducted to isolate pure bacterial culture by using standard methods. Next, S. viridans was assessed for sensitivity to antibacterial agents (n = 78) according to the 2018 clinical recommendations. Initially, antibiotic resistance was assessed by disk-diffusion method as a routine approach broadly used in clinical laboratory. After that, the minimal inhibitory concentration was measured by using AutoScan 4 Microscan analyzer (bacteriological semi-automatic analyzer, Beckman Coulter, USA) to identify and determine antibacterial sensitivity. Results. A disk-diffusion method allowed to find in sputum samples streptococci resistant to penicillin in 28.2% cases, ampicillin — in 42.3% and cefazolin — in 43.6%. While assessing the minimal inhibitory concentration for antibacterial agents, similar data were obtained. Good sensitivity was found for cefotaxime, ceftriaxone, cefepime, fluoroquinolones and vancomycin.
first_indexed 2024-04-11T03:58:34Z
format Article
id doaj.art-8cca52292bdf46798cb964a133e45135
institution Directory Open Access Journal
issn 2220-7619
2313-7398
language Russian
last_indexed 2024-04-11T03:58:34Z
publishDate 2021-03-01
publisher Sankt-Peterburg : NIIÈM imeni Pastera
record_format Article
series Инфекция и иммунитет
spelling doaj.art-8cca52292bdf46798cb964a133e451352023-01-02T00:08:14ZrusSankt-Peterburg : NIIÈM imeni PasteraИнфекция и иммунитет2220-76192313-73982021-03-0111237137610.15789/2220-7619-SOS-1241896Sensitivity of <i>Streptococcus</i> <i>viridans</i> to antibacterial agents in HIV-positive patients coupled to respiratory diseasesL. V. Puzyreva0A. V. Mordyk1L. A. Rodkina2I. V. Zhitina3A. V. Timofeeva4Omsk State Medical UniversityOmsk State Medical UniversityInfectious Diseases Clinical Hospital No. 1 named after Dalmatov D.M.Infectious Diseases Clinical Hospital No. 1 named after Dalmatov D.M.Infectious Diseases Clinical Hospital No. 1 named after Dalmatov D.M.The streptococcus group consists of multiple species of globular Gram-positive facultative anaerobic bacteria, the classification of which is based on assessing their capacity to erythrocyte hemolysis. The viridans group streptococci produce a green coloration being a part of normal microflora in the oral cavity. However, in case of developing immunodeficiency states, oncology, and neutropenia, this pathogen can cause diseases such as bacteremia, sepsis, endocarditis, as well as pneumonia in some cases. Respiratory diseases commonly require medical assistance in HIV-infected patient cohort. The role of commensal S. viridans in development of bacterial diseases in HIV-infected patients remains poorly examined. A potential association between S. viridans and other bacterial communities, including pathogenic microorganisms is obscure. In addition, it might be worth evaluating sensitivity of S. viridans to antibacterial agents in regions with high HIV infection incidence. The aim of the study was to evaluate sensitivity to antibiotics in sputum viridans group streptococci collected from HIV-infected patients with symptomatic pneumonia. Materials and methods. The data on sputum microbiological study conducted within the 01.01.2012—01.01.2019 interval were collected from all HIV-infected patients with suspected pneumonia (n = 684) and analyzed at the Infectious Clinical Hospital No. 1 named after D.M. Dalmatov, among which S. viridans was detected in 193 patients (28.2%). Bacteriological examination of patient samples was conducted to isolate pure bacterial culture by using standard methods. Next, S. viridans was assessed for sensitivity to antibacterial agents (n = 78) according to the 2018 clinical recommendations. Initially, antibiotic resistance was assessed by disk-diffusion method as a routine approach broadly used in clinical laboratory. After that, the minimal inhibitory concentration was measured by using AutoScan 4 Microscan analyzer (bacteriological semi-automatic analyzer, Beckman Coulter, USA) to identify and determine antibacterial sensitivity. Results. A disk-diffusion method allowed to find in sputum samples streptococci resistant to penicillin in 28.2% cases, ampicillin — in 42.3% and cefazolin — in 43.6%. While assessing the minimal inhibitory concentration for antibacterial agents, similar data were obtained. Good sensitivity was found for cefotaxime, ceftriaxone, cefepime, fluoroquinolones and vancomycin.https://www.iimmun.ru/iimm/article/view/1241sputum microflorastreptococci viridanshiv infectionpneumoniaantibiotic sensitivityminimal inhibitory concentration
spellingShingle L. V. Puzyreva
A. V. Mordyk
L. A. Rodkina
I. V. Zhitina
A. V. Timofeeva
Sensitivity of <i>Streptococcus</i> <i>viridans</i> to antibacterial agents in HIV-positive patients coupled to respiratory diseases
Инфекция и иммунитет
sputum microflora
streptococci viridans
hiv infection
pneumonia
antibiotic sensitivity
minimal inhibitory concentration
title Sensitivity of <i>Streptococcus</i> <i>viridans</i> to antibacterial agents in HIV-positive patients coupled to respiratory diseases
title_full Sensitivity of <i>Streptococcus</i> <i>viridans</i> to antibacterial agents in HIV-positive patients coupled to respiratory diseases
title_fullStr Sensitivity of <i>Streptococcus</i> <i>viridans</i> to antibacterial agents in HIV-positive patients coupled to respiratory diseases
title_full_unstemmed Sensitivity of <i>Streptococcus</i> <i>viridans</i> to antibacterial agents in HIV-positive patients coupled to respiratory diseases
title_short Sensitivity of <i>Streptococcus</i> <i>viridans</i> to antibacterial agents in HIV-positive patients coupled to respiratory diseases
title_sort sensitivity of i streptococcus i i viridans i to antibacterial agents in hiv positive patients coupled to respiratory diseases
topic sputum microflora
streptococci viridans
hiv infection
pneumonia
antibiotic sensitivity
minimal inhibitory concentration
url https://www.iimmun.ru/iimm/article/view/1241
work_keys_str_mv AT lvpuzyreva sensitivityofistreptococcusiiviridansitoantibacterialagentsinhivpositivepatientscoupledtorespiratorydiseases
AT avmordyk sensitivityofistreptococcusiiviridansitoantibacterialagentsinhivpositivepatientscoupledtorespiratorydiseases
AT larodkina sensitivityofistreptococcusiiviridansitoantibacterialagentsinhivpositivepatientscoupledtorespiratorydiseases
AT ivzhitina sensitivityofistreptococcusiiviridansitoantibacterialagentsinhivpositivepatientscoupledtorespiratorydiseases
AT avtimofeeva sensitivityofistreptococcusiiviridansitoantibacterialagentsinhivpositivepatientscoupledtorespiratorydiseases